Initial studies were performed to assess whether AD patients showed any changes in the following main and most represented cell subsets of human peripheral blood: total CD3+ T-lymphocytes, CD14+ monocytes, CD19+ B-lymphocytes, and CD56+ NK cells. The gene discussed is CD19; the disease is Alzheimer disease.